Desktop Site
|
28 Mar 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
Notices
|
S&P
BSE SENSEX
73,651.35
+655.04
+0.90 %
Corporate Announcement
Security Code
532296
Company
GLENMARK PHARMACEUTICALS LTD.
Exchange Received Time
30/04/2020 08:35:53
Exchange Disseminated Time
30/04/2020 08:35:59
Time Taken
00:00:06
Announcement under Regulation 30 (LODR)-Press Release / Media Release |
4/30/2020 8:35:54 AM
Glenmark receives approval from the regulator (DCGI) to conduct Clinical Trials in India on Favipiravir Antiviral tablets for COVID-19 patients
Attachment
<< Back
Recently Viewed